Table 9.

Patient self-testing and self-management studies.

Study
Study Groups
No. of Patients
Time in Range (% or days)
Major Hemorrhage (%/pt-yr)
Thromboembolism (%/pt-yr)
White160  1989   PST   23   93   0   0  
  ACC   23   75   0   0  
Anderson161  1993   PST   40   —   0   0  
Beyth162  1997   PST   162   56   5.7   9  
  UC   163   33   12   13  
Ansell163  1995   PSM   20   89   0   0  
  ACC   20   68   0   0  
Horstkotte143  1996   PSM   75   92   4.5*  0.9  
  UC   75   59   10.9*  3.6  
Hasenkam164  1997   PSM   20   77   NA   NA  
  UC   20   53   NA   NA  
Sawicki165  1999   PSM   90   57/53**  2.2   2.2  
  UC   89   34/43**  2.2   4.5  
Koertke166  2000   PSM   581   78   1.8   2.4  
  UC   567   60   2.7   4.5  
Abbreviations: PST, patient self-testing; PSM, patient self-management; ACC, anticoagulation clinic; UC, usual care  
Study
Study Groups
No. of Patients
Time in Range (% or days)
Major Hemorrhage (%/pt-yr)
Thromboembolism (%/pt-yr)
White160  1989   PST   23   93   0   0  
  ACC   23   75   0   0  
Anderson161  1993   PST   40   —   0   0  
Beyth162  1997   PST   162   56   5.7   9  
  UC   163   33   12   13  
Ansell163  1995   PSM   20   89   0   0  
  ACC   20   68   0   0  
Horstkotte143  1996   PSM   75   92   4.5*  0.9  
  UC   75   59   10.9*  3.6  
Hasenkam164  1997   PSM   20   77   NA   NA  
  UC   20   53   NA   NA  
Sawicki165  1999   PSM   90   57/53**  2.2   2.2  
  UC   89   34/43**  2.2   4.5  
Koertke166  2000   PSM   581   78   1.8   2.4  
  UC   567   60   2.7   4.5  
Abbreviations: PST, patient self-testing; PSM, patient self-management; ACC, anticoagulation clinic; UC, usual care  
*

Major and minor bleeding;

**

time in range at 3 months and 6 months.